Application 208201
- Type
- ANDA
- Sponsor
- TARO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NAFTIFINE HYDROCHLORIDE | NAFTIFINE HYDROCHLORIDE | GEL;TOPICAL | 2% | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51672-1376 | Naftifine Hydrochloride | Naftifine Hydrochloride | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-1376 | Naftifine Hydrochloride | Naftifine Hydrochloride | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-1376 | Naftifine Hydrochloride | Naftifine Hydrochloride | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-1376 | Naftifine Hydrochloride | Naftifine Hydrochloride | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 58824 | ORIG | 2019-05-22 |